65 phenotypes from 4 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Otcem1(IMPC)Tcp/Otc+ C57BL/6NCrl-Otcem1(IMPC)Tcp/Tcp	absent vibrissae	J:211773
	enlarged thymus	J:211773
	increased circulating alanine transaminase level	J:211773
	increased circulating triglyceride level	J:211773
Otcspf-ash/Y B6EiC3Sn a/A-Otcspf-ash/J	abnormal spatial learning	J:108979
	abnormal spatial reference memory	J:108979
	abnormal spatial working memory	J:108979
	decreased body size	J:108979
	increased circulating ammonia level	J:108979
	increased susceptibility to endotoxin shock	J:108979
Otcspf-ash/Y involves: C57BL/6	abnormal homeostasis	J:23205
	increased susceptibility to induced morbidity/mortality	J:23205
	increased susceptibility to parasitic infection	J:23205
	oroticaciduria	J:23205
Otcspf-ash/Otc+ involves: C57BL/6	oroticaciduria	J:23205
Otcspf-ash/Y Not Specified	abnormal enzyme/coenzyme activity	J:26976
	abnormal mitochondrial physiology	J:26976
	abnormal protein level	J:26976
	decreased ornithine carbamoyltransferase activity	J:7199
	enlarged liver	J:26976
	increased circulating ammonia level	J:26977
	increased liver weight	J:26976
	oroticaciduria	J:26977
	sparse hair	J:26977
	wrinkled skin	J:26977
Otcspf-ash/Otc+ Not Specified	sparse hair	J:5476
Otcspf-ash/Otcspf Not Specified	abnormal hair growth	J:5476
Otcspf-J/Y C57BL/6J-Otcspf-J/J	abnormal amino acid level	J:226209
	abnormal blood homeostasis	J:226209
	abnormal circulating amino acid level	J:226209
	abnormal coat/hair pigmentation	J:226209
	decreased body size	J:226209
	sparse hair	J:30778, J:226209
Otcspf-J/Otc+ C57BL/6J-Otcspf-J/J	focal hair loss	J:30778
Otcspf/Y involves: 22A/R * C57BL/6J	decreased body size	J:5653
	decreased ornithine carbamoyltransferase activity	J:5653
	orotic acid urinary bladder stones	J:5653
	postnatal lethality	J:5653
	sparse hair	J:5653
	wrinkled skin	J:5653
Otcspf/Y involves: C3H/HeJ * C57BL/6J	abnormal eating behavior	J:31237
	circling	J:31237
	decreased body size	J:31237
	decreased circulating arginine level	J:31237
	decreased circulating citrulline level	J:31237
	decreased circulating ornithine level	J:31237
	decreased grooming behavior	J:31237
	decreased locomotor activity	J:31237
	increased circulating ammonia level	J:31237
	increased circulating glutamine level	J:31237
	oroticaciduria	J:31237
	premature death	J:31237
	priapism	J:31237
	sparse hair	J:31237
	tonic-clonic seizures	J:31237
	tremors	J:31237
	weight loss	J:31237
	wrinkled skin	J:31237
Otcspf/Otc+ involves: C3H/HeJ * C57BL/6J	reduced female fertility	J:31237
Otcspf/Y involves: C57BL/6	abnormal body temperature homeostasis	J:1966
	abnormal brain morphology	J:1966
	abnormal head movements	J:1966
Otcspf/Y involves: CD-1	abnormal brain morphology	J:19848, J:21306, J:23195
	abnormal cholinergic neuron morphology	J:23195
	abnormal enzyme/coenzyme activity	J:2774, J:19848, J:23195
	abnormal kidney morphology	J:21306
	abnormal liver morphology	J:21306
	abnormal metabolism	J:784, J:2774
	abnormal testis morphology	J:21306
	decreased ornithine carbamoyltransferase activity	J:23195
	impaired passive avoidance behavior	J:31237
	increased circulating ammonia level	J:784, J:2774, J:23195
	increased circulating glutamine level	J:784
	increased glutamine level	J:784
	oroticaciduria	J:16786
Otcspf/Otc+ Not Specified	abnormal circulating amino acid level	J:23017
	abnormal enzyme/coenzyme activity	J:23017
	decreased ornithine carbamoyltransferase activity	J:7789
	delayed hair appearance	J:26975
	focal hair loss	J:26975
	oroticaciduria	J:23017
Otcspf/Y Not Specified	abnormal amino acid level	J:22268
	abnormal brain morphology	J:23017
	abnormal cerebral cortex pyramidal cell morphology	J:48733
	abnormal circulating amino acid level	J:22268, J:23017
	abnormal dendrite morphology	J:48733
	abnormal liver morphology	J:23017
	abnormal nucleotide metabolism	J:3633
	abnormal sleep behavior	J:30359
	alopecia	J:30359
	decreased body size	J:23017
	decreased brain size	J:48733
	decreased ornithine carbamoyltransferase activity	J:22268, J:23017
	decreased ornithine level	J:22268
	enlarged brain ventricles	J:48733
	hyperactivity	J:23017, J:30359
	increased circulating ammonia level	J:23017
	orotic acid urinary bladder stones	J:30359
	oroticaciduria	J:23017
	sparse hair	J:23017
Otcspf/Otcspf involves: CD-1	abnormal amino acid level	J:784
	abnormal metabolism	J:784
	increased circulating ammonia level	J:784
Otcspf/Otcspf Not Specified	abnormal coat appearance	J:30359
	decreased body size	J:30359
	sparse hair	J:30359
	wrinkled skin	J:30359